TOXICOLOGY IN VITRO is a premier journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest advancements in the field of toxicology, particularly through in vitro methodologies. With an ISSN of 0887-2333 and an E-ISSN of 1879-3177, this journal serves as a critical platform for researchers aiming to disseminate their findings in toxicology, emphasizing innovative approaches and applications in pharmacology and toxicology. Featuring a commendable impact factor and classified in the second quartile (Q2) for both Medicine (miscellaneous) and Toxicology in 2023, the journal holds a significant position within the academic community, ranking 41st out of 133 in the Toxicology category according to Scopus, representing the 69th percentile. Despite being a subscription-based publication, it continuously attracts submissions from leading scientists worldwide, fostering a vibrant exchange of scientific knowledge. Since its inception in 1987, TOXICOLOGY IN VITRO has consistently aimed to enhance understanding of toxicological challenges, making it an invaluable resource for professionals, students, and researchers dedicated to developing safer pharmaceuticals and understanding the biological pathways influenced by potential toxic agents.

Epigenomes is a distinguished open access journal published by MDPI, dedicated to advancing the field of epigenetics and its interdisciplinary connections to biochemistry, genetics, and molecular biology. Since its inception in 2017, this journal has provided a transparent platform for researchers to share their findings, contributing to a deeper understanding of epigenetic mechanisms and their implications in health, toxicology, and mutagenesis. Ranked in the Q2 quartile across multiple categories, including biochemistry and genetics, Epigenomes is recognized for its scholarly contributions, reflected in its notable Scopus rankings. Readers benefit from a wealth of open access articles, fostering innovation and collaboration within the academic community. With its headquarters in Switzerland and an unwavering commitment to scientific rigor, Epigenomes is positioned as a vital resource for researchers, professionals, and students seeking to deepen their insights into the epigenomic landscape.

Inhalation Toxicology, published by Taylor & Francis Ltd, is a premier journal dedicated to advancing the field of toxicology with a particular focus on inhalation exposure and its impact on human health. Established in 1989, this journal provides a vital platform for original research, reviews, and case studies that explore the toxicological effects of inhaled substances, making it essential reading for researchers, health professionals, and regulatory scientists. With an Impact Factor that situates it in the Q3 category in both Health, Toxicology and Mutagenesis, the journal asserts its relevance within the scientific community, particularly emphasizing its contributions as indexed by Scopus rankings in related fields. Although it follows a traditional access model, the journal's commitment to delivering high-quality research continues to foster significant discussions and advancements in understanding inhalation toxicology. For those at the forefront of environmental science and pharmacology, Inhalation Toxicology is an indispensable resource for both current research and future innovations in the discipline.

TOXICOLOGY LETTERS is a prominent journal dedicated to advancing the field of toxicology, providing a platform for high-quality research and reviews that explore the effects of chemical substances on biological systems. Published by Elsevier Ireland Ltd, this peer-reviewed journal has established itself as a vital resource in toxicological research since its inception in 1977, with a convergence of studies extending to 2024. With an impressive Scopus ranking, positioned at #28 out of 133 in the Toxicology category, TOXICOLOGY LETTERS garners a respectable percentile of 79, highlighting its significance in the academic community. Although it is not an open-access journal, its research is accessible through institutional subscriptions, ensuring that critical insights into human health and environmental safety are disseminated effectively. Being categorized in the Q2 quartile in both Medicine (miscellaneous) and Toxicology for 2023 further emphasizes its relevance and impact in these fields. This journal aims to foster collaboration between researchers and professionals, encouraging the exploration of innovative solutions to chemical hazards and the promotion of safer practices in pharmacology and toxicology.

Genes and Environment is a premier interdisciplinary journal published by BMC that explores the dynamic interplay between genetic factors and environmental influences shaping health and behavior. Since its inception, the journal has gained recognition for its commitment to providing open access (since 2015) to groundbreaking research, fostering an inclusive platform for scholars worldwide. With an ISSN of 1880-7046 and an E-ISSN of 1880-7062, Genes and Environment consistently ranks in Q2 in Environmental Science, Q3 in Genetics, and Q2 in Social Psychology according to the 2023 category quartiles, highlighting its significant contributions to these fields. The journal is headquartered in the United Kingdom and has a diverse portfolio of research spanning from 2006 to 2024. It is recognized in Scopus with commendable rankings across various disciplines. By fostering dialogue among researchers, professionals, and students, Genes and Environment serves as a vital resource for understanding complex biological interactions with environmental factors, ultimately aiming to advance knowledge and inform public policy.

Journal of Biochemical and Molecular Toxicology, published by Wiley, plays a pivotal role in the advancement of knowledge within the fields of biochemistry, toxicology, and molecular biology. Established in 1998, this esteemed journal has garnered a significant reputation, evidenced by its current placement in the Q2 quartile across several categories, including Biochemistry, Health, Toxicology and Mutagenesis, and Medicine. With an ISSN of 1095-6670 and an E-ISSN of 1099-0461, it serves an international audience, offering critical insights and innovative research that shape our understanding of biochemical interactions and toxicological assessments. While it does not operate on an open-access model, the journal ensures rigorous peer review and high-quality publication standards, making it a valuable resource for researchers, professionals, and students dedicated to the exploration of molecular toxicology. The journal's recognized impact within the scientific community is reflected in its competitive rankings among specialized journals, fostering significant contributions to both academic and applied contexts.

TOXICOLOGY, published by Elsevier Ireland Ltd, is a prestigious peer-reviewed journal specializing in the field of toxicology. With an ISSN of 0300-483X and an E-ISSN of 1879-3185, this journal provides a vital platform for researchers, professionals, and students to disseminate and access groundbreaking studies from 1973 to present, with a convergence set until 2024. Recognized for its high impact, it holds a Q1 ranking in Toxicology category and ranks #18 out of 133 in Scopus's sector of Pharmacology, Toxicology, and Pharmaceutics, placing it in the 86th percentile. While the journal is not open access, it nonetheless offers a rich collection of research articles that enhance the understanding of toxicological science and its applications. The journal's objectives encompass advancing knowledge in the toxicological evaluation of substances, promoting safety in public health, and fostering dialogue among scholars. As a key resource in the field, TOXICOLOGY plays a crucial role in advancing research and informing practices related to toxicological risks and safety assessments.

The International Journal of Toxicology, published by SAGE Publications Inc, serves as a cornerstone of scholarly research in the field of toxicology, with an established history dating back to 1982. This esteemed journal, ISSN 1091-5818 and E-ISSN 1092-874X, functions within the Q3 quartile in Toxicology, ranking 94 out of 133 in the Pharmacology, Toxicology and Pharmaceutics category per Scopus metrics, reflecting its commitment to advancing scientific understanding in this critical area. The journal not only aims to disseminate high-quality research but also encourages open access to vital studies, thus fostering collaboration and innovation among researchers, professionals, and students alike. With a focus on various aspects of toxicology, including but not limited to environmental, clinical, and molecular toxicology, the International Journal of Toxicology is dedicated to bridging gaps in toxicity research and promoting safe practices across numerous disciplines. As it converges towards 2024, the journal continues to play a vital role in shaping the discourse surrounding the implications of exposure to toxic substances in human health and the environment.

Molecular & Cellular Toxicology, published by the Korean Society Toxicogenomics & Toxicoproteomics (KSTT), is a significant journal in the field of toxicology, providing crucial insights into molecular mechanisms underlying toxic responses. With an ISSN of 1738-642X and E-ISSN 2092-8467, this journal serves as a vital platform for researchers, professionals, and students interested in the latest findings and advancements in toxicology, health, and environmental science. Although it operates under a subscription model, it maintains rigorous peer review standards, contributing to its respectable Q3 classification in Health, Toxicology and Mutagenesis, and its Q2 standing in Pharmacology, Toxicology, and Pharmaceutics. The journal, intersecting with innovative aspects of pharmacology and public health, aims to foster a deeper understanding of toxicological impacts on cellular processes and overall health. Located in Germany and supported by a dedicated editorial board, Molecular & Cellular Toxicology stands out in the academic community, encouraging interdisciplinary discourse and collaboration to address critical toxicological challenges. Engage with us for cutting-edge research that informs and shapes the future of toxicological science.

Journal of Hazardous Materials Letters, published by ELSEVIER, is a premier open access journal that has rapidly gained prominence in the fields of Environmental Chemistry, Environmental Engineering, Health, Toxicology and Mutagenesis, Pollution, and Waste Management and Disposal since its inception in 2020. With an impressive categorization in the top quartile (Q1) across all its relevant disciplines in 2023, this journal ranks favorably within the Scopus database, positioning itself in the upper echelons of Environmental Science—ranked 23rd in Environmental Engineering and 19th in Health, Toxicology and Mutagenesis among its peers. It serves as a vital platform for the dissemination of high-quality research focused on addressing hazardous materials and their impacts on health and the environment. The journal's commitment to open access facilitates immediate and broad dissemination of research findings, ensuring that essential knowledge reaches a global audience of researchers, professionals, and students eager to advance the field. With its ongoing convergence into 2024, the Journal of Hazardous Materials Letters continues to drive innovation and influence practice in managing hazardous materials for a sustainable future.